A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill ...

Among men worldwide, prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths. As the world's population ages, the number of prostate cancer patients is expected ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment at Penn Medicine Radiation Oncology in Philadelphia. The diagnosis followed ...